Medartis Holding AG (MDRSF) Research
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.
Market snapshot
- Symbol
- MDRSF
- Price
- $115
- Day change
- 0.00%
- Market cap
- $922.3M
- P/E ratio
- 110.34x
- 52-week range
- 66.68-115
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
Peer companies
Open Medartis Holding AG (MDRSF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.